Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

Authors: Bhatt, Ankeet S | The Lancet. Diabetes & Endocrinology | October 1, 2024 | PubMed abstract

Explore all publications

Back To Top